AdaptHealth (AHCO) Competitors

AdaptHealth (NASDAQ:AHCO) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Which has more risk & volatility, AHCO or RDNT?

AdaptHealth has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500.

Do analysts rate AHCO or RDNT?

AdaptHealth presently has a consensus target price of $13.40, suggesting a potential upside of 48.56%. RadNet has a consensus target price of $69.75, suggesting a potential upside of 14.08%. Given AdaptHealth's higher probable upside, research analysts clearly believe AdaptHealth is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
RadNet	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.40

Does the media favor AHCO or RDNT?

In the previous week, RadNet had 15 more articles in the media than AdaptHealth. MarketBeat recorded 20 mentions for RadNet and 5 mentions for AdaptHealth. RadNet's average media sentiment score of 0.72 beat AdaptHealth's score of 0.13 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
RadNet	7 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger valuation and earnings, AHCO or RDNT?

RadNet has lower revenue, but higher earnings than AdaptHealth. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.25B	0.37	-$678.90M	$0.57	15.82
RadNet	$1.87B	2.45	$3.04M	-$0.43	-142.19

Do insiders & institutionals have more ownership in AHCO or RDNT?

82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 1.6% of AdaptHealth shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is AHCO or RDNT more profitable?

RadNet has a net margin of -0.25% compared to AdaptHealth's net margin of -6.57%. AdaptHealth's return on equity of 9.62% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-6.57%	9.62%	3.18%
RadNet	-0.25%	4.29%	1.45%

Does the MarketBeat Community believe in AHCO or RDNT?

RadNet received 266 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.17% of users gave RadNet an outperform vote while only 62.94% of users gave AdaptHealth an outperform vote.

Company	Underperform	Outperform
AdaptHealth	Outperform Votes 90 62.94%	Underperform Votes 53 37.06%
RadNet	Outperform Votes 356 66.17%	Underperform Votes 182 33.83%

Summary

RadNet beats AdaptHealth on 10 of the 19 factors compared between the two stocks.